Continue Reading on TOI App
Open
OPEN APP

Bharat Biotech targets 1 billion/year doses by 2021-end

HYDERABAD: Amid a growing clamour for ramp-up of Covaxin capacity, its developer

Bharat Biotech

has decided to deploy its

Chiron

Behring facility in

Gujarat

to boost output by another 200 million doses annually.


This will scale up production to nearly 1 billion doses a year by 2021 end, a top Bharat

Biotech

executive said on Thursday. “The company plans to produce 200 million doses of Covaxin per annum,” Bharat Biotech joint MD Suchitra Ella tweeted about the new facility.
Continue Reading
Follow Us On Social Media
end of article
More Trending Stories
Visual Stories
More Visual Stories
UP NEXT
Do Not Sell Or Share My Personal Information